Matthew E. RadlerAssociateHonigman Miller Schwartz and Cohn LLPWebsitewww.honigman.comOrganization ProfileFull ProfileConnectEmail313.465.7716 Professional Biography Mr. Radler is a labor and employment attorney who focuses his practice on wage and hour matters and assists in litigating noncompete, trade secret and employment dispute matters. More Legal and Business Bylines From Matthew E. Radler Federal Court Extends Deadline in Appeal of FLSA Amended Overtime Regulations While Government Decides Whether to Press Case or Drop It - (Posted On Monday, February 27, 2017) Seventh Circuit Invalidates Class Action Waivers and Sets Stage for Supreme Court Battle - (Posted On Monday, June 06, 2016) Major Revisions to Federal Overtime Exemptions are One Step Closer to Taking Effect, and Sooner Than You May Have Expected - (Posted On Friday, March 18, 2016) 2016 Ushers in Patchwork of New Minimum Wage Laws - (Posted On Thursday, January 21, 2016) Current Legal Analysis Balancing the Scales: How to Use “Legitimate Interest” to Process Personal Data “Fairly” by: Charles-Albert Helleputte , Claire Murphy Senate Judiciary Subcommittee Holds Back Two Key Patent Reform Bills by: Christopher M. Bruno UPC Court of Appeal Rules on Suspending First Instance Enforcement, Managing Director Liability by: Lisa Nassi FINRA Facts and Trends: November 2024 by: Joshua Klein , Russell W. Gallaro Dividing Cryptocurrency in a New Jersey Divorce: What You Need to Know by: Louis M. Ragone New Pay Transparency Law to Go into Effect Beginning June 1, 2025 by: Ari G. Burd , Jeri L. Abrams Upcoming Events Dec 10 2024 Legal AI Week 2024 Nov 21 2024 Third-Party Litigation Funding through a Transatlantic Lens Nov 21 2024 CC&Rs and Easements for Mixed-Use Projects: Best Practices for Developers Nov 21 2024 AI Patent Eligibility: Processing the USPTO's New Guidance Nov 21 2024 Update of 2024 California Employment Law Cases Nov 25 2024 2024 Election: Impact on the Health Care Legal and Policy Landscape Webinar Dec 4 2024 TSCA 30/30 - December 4, 2024 Dec 4 2024 GLP-1 Drugs: What's Next after FDA's Resolution of Drug Shortages Print
